Live Analyst Rating Changes 23719 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Scott Power
MORG

Scott Power

Morgans
Wall Street Analyst
★★★☆☆
#1874
on 13Foresight · ranked by our own returns
53%
Success Rate
-1.6%
Average Return
10 of 19 calls profitable · -5.7% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 53% of Scott Power's ratings turned a profit when each position was held for 1 year — averaging -1.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

49 Buy 0 Hold 0 Sell
Scott's Stock Coverage 13 ratings · 2026-08-13
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AU:IMR
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
 Aug 11, 2026 BUY Strong Buy
+47.7% avg upside
1 analyst
$2.90
47.68% Upside
 · ·
AU:BB1
Blinklab Limited
 Aug 11, 2026 BUY Strong Buy
+158.9% avg upside
1 analyst
$1.76
158.89% Upside
 · ·
AU:MX1
Micro-X Ltd.
 Aug 03, 2026 BUY Strong Buy
+175.9% avg upside
1 analyst
$0.08
175.93% Upside
 -9.7% ·
AU:PNV
Polynovo
Jul 30, 2026 BUY Strong Buy
+91.2% avg upside
5 analysts
$1.48
59.21% Upside
 +1.2% ·
AU:IPD
Impedimed Limited
 Jul 29, 2026 BUY Strong Buy
+1380.0% avg upside
5 analysts
$0.01
99.93% Upside
 +50.0% ·
AU:TTX
Tetratherix Limited
 Jul 29, 2026 BUY Strong Buy
+25.9% avg upside
1 analyst
$8.59
25.88% Upside
 +4.0% ·
AU:ARX
Aroa Biosurgery Ltd
 May 27, 2026 BUY Strong Buy
+62.2% avg upside
3 analysts
$0.79
33.93% Upside
 -17.6% ·
AU:SIG
Sigma Healthcare Ltd
 Apr 12, 2026 BUY Strong Buy
+112.7% avg upside
10 analysts
$3.36
12.86% Upside
 +11.6% ·
AU:CBL
Control Bionics Ltd.
 Jan 08, 2024 HOLD Hold
-16.7% avg upside
1 analyst
$0.05
16.71% Downside
 +41.3% ·
AU:NAN
Nanosonics Limited
 Aug 23, 2023 BUY Hold
+31.8% avg upside
7 analysts
$5.32
49.86% Upside
 -35.0% ·
AU:M7T
Mach7 Technologies
 Feb 28, 2022 BUY Strong Buy
+286.6% avg upside
5 analysts
$1.55
453.50% Upside
 -20.4% ·
AU:MVF
Monash IVF Group Ltd
 Feb 18, 2022 BUY Strong Buy
+40.7% avg upside
7 analysts
$1.20
71.42% Upside
 +1.0% ·
AU:REG
Regis Healthcare Ltd.
 Dec 14, 2021 HOLD Buy
-2.5% avg upside
6 analysts
$1.89
68.93% Downside
 +11.5% ·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Scott Power — Frequently Asked Questions
How accurate are Scott Power's stock ratings?
Based on the calls 13Foresight could measure, about 53% of Scott's ratings were profitable over a one-year hold, with an average return of -1.6% per rating, or -5.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Scott ranked on 13Foresight?
Scott Power is currently ranked #1874 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Scott cover?
Scott most recently has ratings on AU:IMR, AU:BB1, AU:MX1, AU:PNV, AU:IPD, AU:TTX, AU:ARX, AU:SIG, AU:CBL, AU:NAN, AU:M7T, AU:MVF and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.